MA56118A - Vaccin vivant liquide stabilisé - Google Patents

Vaccin vivant liquide stabilisé

Info

Publication number
MA56118A
MA56118A MA056118A MA56118A MA56118A MA 56118 A MA56118 A MA 56118A MA 056118 A MA056118 A MA 056118A MA 56118 A MA56118 A MA 56118A MA 56118 A MA56118 A MA 56118A
Authority
MA
Morocco
Prior art keywords
liquid vaccine
live liquid
stabilized live
stabilized
vaccine
Prior art date
Application number
MA056118A
Other languages
English (en)
Inventor
David Pierre Corneille
Bradley Eddy
Noel Yves Henri Jean Genin
Original Assignee
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc
Publication of MA56118A publication Critical patent/MA56118A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA056118A 2019-06-10 2020-06-05 Vaccin vivant liquide stabilisé MA56118A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962859491P 2019-06-10 2019-06-10

Publications (1)

Publication Number Publication Date
MA56118A true MA56118A (fr) 2022-04-13

Family

ID=71895188

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056118A MA56118A (fr) 2019-06-10 2020-06-05 Vaccin vivant liquide stabilisé

Country Status (4)

Country Link
US (1) US11813322B2 (fr)
EP (1) EP3980058A1 (fr)
MA (1) MA56118A (fr)
WO (1) WO2020251843A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024228212A1 (fr) * 2023-05-01 2024-11-07 Biovet Private Limited Formulations de bio-lumpivaxin et leur procédé de préparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
RU2643929C2 (ru) * 2012-04-23 2018-02-06 Бхарат Байотек Интернэшнл Лимитед Новые ротавирусные вакцинные композиции и способ получения вышеуказанных композиций
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas

Also Published As

Publication number Publication date
WO2020251843A1 (fr) 2020-12-17
US11813322B2 (en) 2023-11-14
EP3980058A1 (fr) 2022-04-13
US20200384101A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
EP4045480A4 (fr) Formulations pharmaceutiques
MA46766A (fr) Vaccin antigrippal
EP3580565A4 (fr) Dosage utilisant différentes hauteurs d'espacement
EP3668541A4 (fr) Formulations de vaccin pneumococcique conjugué
HRP20251619T1 (hr) Formulacije pneumokoknih konjugiranih cjepiva
EP4233846C0 (fr) Formulations pharmaceutiques
EP3603619A4 (fr) Formulation d'adjuvant vaccinal
MA53543A (fr) Vaccins peptidiques
IL285674A (en) Pharmaceutical formulations
DK3886820T3 (da) Kapselformuleringer
EP3746080A4 (fr) Formulations pharmaceutiques
DK3709970T3 (da) Linezolidformuleringer
EP3344293A4 (fr) Compositions de vaccin stabilisés de vlp
DK3307239T3 (da) Formuleringer til indgivelse af RSV- og norovirusantigener i tyndtarmen
DK3280447T3 (da) Farmaceutiske formuleringer
DK3762009T3 (da) Toxin-afledte indgivelseskonstrukter til oral indgivelse
DK4027973T3 (da) Formuleringer til lægemiddeladministration
DK3247394T3 (da) Farmaceutisk formulering omfattende anti-egfr-antistof
DK3706710T3 (da) Formuleringer med forlænget frigivelse til intraartikulære anvendelser
MA56118A (fr) Vaccin vivant liquide stabilisé
IT201700038005A1 (it) Dispositivo per la somministrazione di sostanze
EP3866847A4 (fr) Vaccin antiviral
PL3787596T3 (pl) Ulepszone formulacje farmaceutyczne
EP3651800C0 (fr) Formulations pharmaceutiques hydrocompressées
EP3697393A4 (fr) Formes posologiques pharmaceutiques